Roy Golan

Roy Golan

Directeur/Membre du Conseil chez NEUROSENSE THERAPEUTICS LTD.

Fortune : 141 353 $ au 31/05/2026

52 ans
Health Technology
Commercial Services
Technology Services

Profil

Roy Golan currently works at Neurosense Therapeutics Ltd., as Independent Director from 2024, My Size, Inc., as Independent Director from 2025, LIVEKIDNEY.BIO, as Chief Financial Officer from 2025, and Biosight Therapeutics, Inc., as Chief Financial Officer.
Mr. Golan also formerly worked at On Track Innovations Ltd., as Controller, PricewaterhouseCoopers (Israel), as Senior Consultant, G.I.
View Ltd., as Vice President-Finance in 2008, Meridian Bioscience Israel Ltd., as President & Chief Financial Officer from 2018 to 2019, Lifeward Ltd., as Chief Financial Officer, KCS Ltd., as Chief Financial Officer in 2012, BioSight Ltd., as Chief Financial Officer & Executive Vice President from 2019 to 2023, NeuroDerm Ltd., as Chief Financial Officer from 2015 to 2018, and Ayala Pharmaceuticals, Inc., as Chief Financial Officer from 2023 to 2024.
Mr. Golan received his graduate degree from Bar-Ilan University and undergraduate degree from The College of Management Academic Studies.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
28/03/2026 160 844 ( 0,46% ) 132 053 $ 31/05/2026
15/12/2025 15 000 ( 0,31% ) 9 300 $ 31/05/2026

Postes actifs de Roy Golan

SociétésPosteDébut
NEUROSENSE THERAPEUTICS LTD. Directeur/Membre du Conseil 01/07/2024
MY SIZE, INC. Directeur/Membre du Conseil 06/03/2025
Directeur Financier/CFO 01/03/2025

Anciens postes connus de Roy Golan

SociétésPosteFin
AYALA PHARMACEUTICALS, INC. Directeur Financier/CFO 25/06/2024
Directeur Financier/CFO 01/01/2023
EXALENZ BIOSCIENCE LTD Directeur Financier/CFO 29/01/2019
NEURODERM LTD Directeur Financier/CFO 01/04/2018
Directeur Financier/CFO 01/01/2012
Voir l'expérience en détail de Roy Golan

Formation de Roy Golan

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

21

Relations au 1er degré

14

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées14

Technology Services

Technology Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Commercial Services

Health Technology

Health Technology

- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT